Ignite Creation Date:
2024-05-06 @ 2:10 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01987011
Status:
COMPLETED
Last Update Posted:
2015-07-03
First Post:
2013-07-22
Brief Title:
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp